“Interleukin-enhancer binding factor 2 expression associates with chemotherapy response in triple-negative breast cancer

Document Type

Presentation

Publication Date

12-1-2019

Clinical Institute

Cancer

Specialty/Research Institute

Oncology

Comments

” San Antonio Breast Cancer Symposium, December 2019 San Antonio, TX, USA; P6-03-11

This document is currently not available here.


Share

COinS